Search Results - "IRVING, W. L."

Refine Results
  1. 1

    Prevalence and risk factors for hepatitis C virus infection in Kech District, Balochistan, Pakistan: most infections remain unexplained. A cross-sectional study by AHMED, F., IRVING, W. L., ANWAR, M., MYLES, P., NEAL, K. R.

    Published in Epidemiology and infection (01-04-2012)
    “…We studied a cross-sectional sample of the population of Kech, a small rural town in Pakistan to determine the prevalence and risk factors for hepatitis C…”
    Get full text
    Journal Article
  2. 2

    Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study by Irving, W. L., James, D. K., Stephenson, T., Laing, P., Jameson, C., Oxford, J. S., Chakraverty, P., Brown, D. W. G., Boon, A. C. M, Zambon, M. C.

    “…Objective To determine whether maternal influenza virus infection in the second and third trimesters of pregnancy results in transplacental transmission of…”
    Get full text
    Journal Article
  3. 3

    Association between MHC Class II Alleles and Clearance of Circulating Hepatitis C Virus by Minton, E. J., Smillie, D., Neal, K. R., Irving, W. L., Underwood, J. C. E., James, V.

    Published in The Journal of infectious diseases (01-07-1998)
    “…The frequencies of HLA class I antigens and class II haplotypes were compared in subjects with previous (polymerase chain reaction [PCR]-negative) or with…”
    Get full text
    Journal Article
  4. 4

    Immunocompromised children and young people are at no increased risk of severe COVID-19 by Chappell, H., Patel, R., Driessens, C., Tarr, A.W., Irving, W.L., Tighe, P.J., Jackson, H.J., Harvey-Cowlishaw, T., Mills, L., Shaunak, M., Gbesemete, D., Leahy, A., Lucas, J.S., Faust, S.N., de Graaf, H.

    Published in The Journal of infection (01-01-2022)
    “…•UK immunocompromised paediatric patients were at no increased risk of severe COVID-19.•Only 4/38 PCR detected infections were admitted to hospital. None had…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: A systematic review by Walker, A. J., Peacock, C. J., Pedergnana, V., Irving, W. L.

    Published in Journal of viral hepatitis (01-05-2018)
    “…Summary Hepatitis C virus (HCV)‐infected patients are at risk of developing hepatocellular carcinoma (HCC). Individuals at heightened risk could be targeted by…”
    Get full text
    Journal Article
  7. 7

    Clinical pathways for patients with newly diagnosed hepatitis C - What actually happens by Irving, W. L., Smith, S., Cater, R., Pugh, S., Neal, K. R., Coupland, C. A. C., Ryder, S. D., Thomson, B. J., Pringle, M., Bicknell, M., Hippisley-Cox, J.

    Published in Journal of viral hepatitis (01-04-2006)
    “…Management of hepatitis C virus (HCV)‐infected individuals requires referral to specialist care. To determine whether patients newly diagnosed as anti‐HCV…”
    Get full text
    Journal Article
  8. 8

    Short-term changes observed in multiparametric liver MRI following therapy with direct-acting antivirals in chronic hepatitis C virus patients by Bradley, C., Scott, R. A., Cox, E., Palaniyappan, N., Thomson, B. J., Ryder, S. D., Irving, W. L., Aithal, G. P., Guha, I. N., Francis, S.

    Published in European radiology (01-06-2019)
    “…Methods We applied multiparametric MRI to assess changes in liver composition, perfusion and blood flow in 17 patients before direct-acting antiviral (DAA)…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Current knowledge and future perspectives on acute hepatitis C infection by Hullegie, S.J., Arends, J.E., Rijnders, B.J.A., Irving, W.L., Salmon, D., Prins, M., Wensing, A.M., Klenerman, P., Leblebicioglu, H., Boesecke, C., Rockstroh, J.K., Hoepelman, A.I.M.

    Published in Clinical microbiology and infection (01-08-2015)
    “…Acute hepatitis C virus (HCV) infections are frequently seen worldwide in certain risk groups, with an annual incidence rate varying between 0.08% and 66%…”
    Get full text
    Journal Article
  11. 11

    TT Virus Infection in Patients with Hepatitis C: Frequency, Persistence, and Sequence Heterogeneity by Irving, William L., Ball, Jonathan K., Berridge, Selina, Curran, Rebecca, Grabowska, Anna M., Jameson, Claire L., Neal, Keith R., Ryder, Steven D., Thomson, Brian J.

    Published in The Journal of infectious diseases (01-07-1999)
    “…TT virus (TTV) was recently identified in the serum of a patient with hepatitis. The role of TTV in liver disease has not been established. Three polymerase…”
    Get full text
    Journal Article
  12. 12

    The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy by Backx, M., Lewszuk, A., White, J. R., Cole, J., Sreedharan, A., van Sanden, S., Diels, J., Lawson, A., Neal, K. R., Wiselka, M. J., Ito, T., Irving, W. L.

    Published in Journal of viral hepatitis (01-03-2014)
    “…Summary Chronic hepatitis C virus (HCV) infection places a considerable economic burden on health services. Cost‐effectiveness analyses of antiviral treatment…”
    Get full text
    Journal Article
  13. 13

    Immunisation with Phage Displaying Peptides Representing Single Epitopes of the Glycoprotein G Can Give Rise to Partial Protective Immunity to HSV-2 by Grabowska, A.M., Jennings, R., Laing, P., Darsley, M., Jameson, C.L., Swift, L., Irving, W.L.

    Published in Virology (New York, N.Y.) (30-03-2000)
    “…Filamentous phage displaying peptides representing single epitopes of the glycoprotein G of HSV-2 (gG2) were used as immunogens via the subcutaneous route in…”
    Get full text
    Journal Article
  14. 14

    Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver disease severity by Curran, Rebecca, Jameson, Claire L, Craggs, Joanna K, Grabowska, Anna M, Thomson, Brian J, Robins, Adrian, Irving, William L, Ball, Jonathan K

    Published in Journal of general virology (01-01-2002)
    “…Division of Microbiology and Infectious Diseases, University of Nottingham, Queen’s Medical Centre, Nottingham NG7 2UH, UK 1 Author for correspondence:…”
    Get full text
    Journal Article
  15. 15

    Acute hepatitis C virus infection: a neglected disease? by Irving, W L

    Published in Gut (01-08-2006)
    “…[...]there remains a possibility that the sex difference in clearance is secondary to differences in age at, and route of, acquisition of infection, although…”
    Get full text
    Journal Article
  16. 16

    Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections by HO, D. W. T, FIELD, P. R, IRVING, W. L, PACKHAM, D. R, CUNNINGHAM, A. L

    Published in Journal of Clinical Microbiology (01-12-1993)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  17. 17

    Autoantibodies in chronic hepatitis C virus infection and their association with disease profile by Williams, M. J., Lawson, A., Neal, K. R., Ryder, S. D., Irving, W. L.

    Published in Journal of viral hepatitis (01-05-2009)
    “…Autoantibodies are commonly detected in chronic hepatitis C (HCV) but their significance remains uncertain. We assessed the prevalence of anti‐nuclear (ANA)…”
    Get full text
    Journal Article
  18. 18

    Reasons for nonuse of antiviral treatment in patients with chronic hepatitis C infection and thrombocytopaenia: a retrospective chart review from five European countries by Rizzetto, M., Grotzinger, K., Theodore, D., Demuth, D., Irving, W. L., Manns, M., Roughley, A., Forssen, U. M.

    Published in Journal of viral hepatitis (01-10-2014)
    “…Summary Antiviral therapy has been shown to reduce the risk of disease progression, liver damage and death in patients with chronic hepatitis C virus (HCV)…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Dendritic cells cultured from mononuclear cells and CD34 cells in myeloma do not harbour human herpesvirus 8 by CULL, G. M, TIMMS, J. M, HAYNES, A. P, RUSSELL, N. H, IRVING, W. L, BALL, J. K, THOMSON, B. J

    Published in British journal of haematology (01-03-1998)
    “…Dendritic cells (DC) are antigen‐presenting cells with the potential to be a powerful adjuvant in the immunotherapy of haematological malignancy, including…”
    Get full text
    Journal Article